Lectines liant le mannose : Questions médicales fréquentes
Nom anglais: Mannose-Binding Lectins
Descriptor UI:D037241
Tree Number:D12.776.503.311
Termes MeSH sélectionnés :
Early Detection of Cancer
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Lectines liant le mannose : Questions médicales les plus fréquentes",
"headline": "Lectines liant le mannose : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Lectines liant le mannose : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-06-13",
"dateModified": "2025-03-10",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Lectines liant le mannose"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Lectines",
"url": "https://questionsmedicales.fr/mesh/D037102",
"about": {
"@type": "MedicalCondition",
"name": "Lectines",
"code": {
"@type": "MedicalCode",
"code": "D037102",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.503"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Lectine liant le mannose",
"alternateName": "Mannose-Binding Lectin",
"url": "https://questionsmedicales.fr/mesh/D037601",
"about": {
"@type": "MedicalCondition",
"name": "Lectine liant le mannose",
"code": {
"@type": "MedicalCode",
"code": "D037601",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.503.311.500"
}
}
}
],
"about": {
"@type": "MedicalCondition",
"name": "Lectines liant le mannose",
"alternateName": "Mannose-Binding Lectins",
"code": {
"@type": "MedicalCode",
"code": "D037241",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Jatinder Singh",
"url": "https://questionsmedicales.fr/author/Jatinder%20Singh",
"affiliation": {
"@type": "Organization",
"name": "Department of Molecular Biology and Biochemistry, Guru Nanak Dev University, Amritsar, India."
}
},
{
"@type": "Person",
"name": "Manpreet Kaur",
"url": "https://questionsmedicales.fr/author/Manpreet%20Kaur",
"affiliation": {
"@type": "Organization",
"name": "Department of Human Genetics, Guru Nanak Dev University, Amritsar, India."
}
},
{
"@type": "Person",
"name": "Namarta Kalia",
"url": "https://questionsmedicales.fr/author/Namarta%20Kalia",
"affiliation": {
"@type": "Organization",
"name": "Department of Molecular Biology and Biochemistry, Guru Nanak Dev University, Amritsar, India."
}
},
{
"@type": "Person",
"name": "Kárita Cláudia Freitas Lidani",
"url": "https://questionsmedicales.fr/author/K%C3%A1rita%20Cl%C3%A1udia%20Freitas%20Lidani",
"affiliation": {
"@type": "Organization",
"name": "Laboratory of Molecular Immunopathology, Clinical Hospital, Federal University of Paraná, Curitiba, Brazil."
}
},
{
"@type": "Person",
"name": "Fabiana Antunes Andrade",
"url": "https://questionsmedicales.fr/author/Fabiana%20Antunes%20Andrade",
"affiliation": {
"@type": "Organization",
"name": "Laboratory of Molecular Immunopathology, Clinical Hospital, Federal University of Paraná, Curitiba, Brazil."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Early Detection of Prostate Cancer in the European Union: Combining Forces with PRAISE-U.",
"datePublished": "2023-09-12",
"url": "https://questionsmedicales.fr/article/37704541",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.eururo.2023.08.002"
}
},
{
"@type": "ScholarlyArticle",
"name": "Metabolomic investigation of urinary extracellular vesicles for early detection and screening of lung cancer.",
"datePublished": "2023-05-16",
"url": "https://questionsmedicales.fr/article/37189121",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s12951-023-01908-0"
}
},
{
"@type": "ScholarlyArticle",
"name": "mHealth Interventions to Improve Cancer Screening and Early Detection: Scoping Review of Reviews.",
"datePublished": "2022-08-15",
"url": "https://questionsmedicales.fr/article/35969450",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.2196/36316"
}
},
{
"@type": "ScholarlyArticle",
"name": "Multibiomarker panels in liquid biopsy for early detection of pancreatic cancer - a comprehensive review.",
"datePublished": "2024-09-02",
"url": "https://questionsmedicales.fr/article/39218911",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s13046-024-03166-w"
}
},
{
"@type": "ScholarlyArticle",
"name": "Salivary Extracellular MicroRNAs for Early Detection and Prognostication of Esophageal Cancer: A Clinical Study.",
"datePublished": "2023-07-01",
"url": "https://questionsmedicales.fr/article/37399999",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1053/j.gastro.2023.06.021"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Acides aminés, peptides et protéines",
"item": "https://questionsmedicales.fr/mesh/D000602"
},
{
"@type": "ListItem",
"position": 3,
"name": "Protéines",
"item": "https://questionsmedicales.fr/mesh/D011506"
},
{
"@type": "ListItem",
"position": 4,
"name": "Lectines",
"item": "https://questionsmedicales.fr/mesh/D037102"
},
{
"@type": "ListItem",
"position": 5,
"name": "Lectines liant le mannose",
"item": "https://questionsmedicales.fr/mesh/D037241"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Lectines liant le mannose - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Lectines liant le mannose",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-15",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Lectines liant le mannose",
"description": "Comment diagnostiquer une déficience en lectines liant le mannose ?\nQuels tests sont utilisés pour évaluer les lectines ?\nLes niveaux de lectines peuvent-ils varier ?\nQuels symptômes peuvent indiquer un problème avec les lectines ?\nPeut-on mesurer les lectines dans d'autres fluides ?",
"url": "https://questionsmedicales.fr/mesh/D037241?mesh_terms=Early+Detection+of+Cancer&page=6#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Lectines liant le mannose",
"description": "Quels symptômes sont associés à une déficience en lectines ?\nLes symptômes varient-ils selon l'âge ?\nY a-t-il des signes cutanés associés ?\nLes symptômes sont-ils toujours visibles ?\nLes symptômes peuvent-ils s'aggraver avec le temps ?",
"url": "https://questionsmedicales.fr/mesh/D037241?mesh_terms=Early+Detection+of+Cancer&page=6#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Lectines liant le mannose",
"description": "Comment prévenir les infections chez les patients déficients ?\nL'alimentation joue-t-elle un rôle dans la prévention ?\nLes exercices physiques sont-ils bénéfiques ?\nY a-t-il des mesures spécifiques à prendre ?\nLes consultations médicales régulières sont-elles importantes ?",
"url": "https://questionsmedicales.fr/mesh/D037241?mesh_terms=Early+Detection+of+Cancer&page=6#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Lectines liant le mannose",
"description": "Quels traitements sont disponibles pour les déficiences en lectines ?\nLes suppléments peuvent-ils aider ?\nLa vaccination est-elle recommandée ?\nY a-t-il des traitements expérimentaux ?\nLes traitements sont-ils personnalisés ?",
"url": "https://questionsmedicales.fr/mesh/D037241?mesh_terms=Early+Detection+of+Cancer&page=6#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Lectines liant le mannose",
"description": "Quelles complications peuvent survenir avec une déficience en lectines ?\nLes infections peuvent-elles être mortelles ?\nY a-t-il un risque accru de cancer ?\nLes complications sont-elles réversibles ?\nComment surveiller les complications ?",
"url": "https://questionsmedicales.fr/mesh/D037241?mesh_terms=Early+Detection+of+Cancer&page=6#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Lectines liant le mannose",
"description": "Quels sont les facteurs de risque pour les déficiences en lectines ?\nL'âge influence-t-il le risque ?\nLes maladies auto-immunes augmentent-elles le risque ?\nLe mode de vie affecte-t-il le risque ?\nLes infections chroniques sont-elles un facteur de risque ?",
"url": "https://questionsmedicales.fr/mesh/D037241?mesh_terms=Early+Detection+of+Cancer&page=6#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une déficience en lectines liant le mannose ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests sanguins peuvent mesurer les niveaux de lectines et évaluer la fonction immunitaire."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour évaluer les lectines ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les tests d'immunoessai et les dosages enzymatiques sont couramment utilisés."
}
},
{
"@type": "Question",
"name": "Les niveaux de lectines peuvent-ils varier ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les niveaux de lectines peuvent fluctuer en fonction de l'état de santé et des infections."
}
},
{
"@type": "Question",
"name": "Quels symptômes peuvent indiquer un problème avec les lectines ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des infections récurrentes ou des maladies auto-immunes peuvent signaler un dysfonctionnement."
}
},
{
"@type": "Question",
"name": "Peut-on mesurer les lectines dans d'autres fluides ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les lectines peuvent également être mesurées dans les fluides corporels comme la salive."
}
},
{
"@type": "Question",
"name": "Quels symptômes sont associés à une déficience en lectines ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent des infections fréquentes, des allergies et des maladies auto-immunes."
}
},
{
"@type": "Question",
"name": "Les symptômes varient-ils selon l'âge ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les symptômes peuvent se manifester différemment chez les enfants et les adultes."
}
},
{
"@type": "Question",
"name": "Y a-t-il des signes cutanés associés ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des éruptions cutanées peuvent survenir en raison de réactions immunitaires anormales."
}
},
{
"@type": "Question",
"name": "Les symptômes sont-ils toujours visibles ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, certains patients peuvent être asymptomatiques malgré une déficience en lectines."
}
},
{
"@type": "Question",
"name": "Les symptômes peuvent-ils s'aggraver avec le temps ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, sans traitement, les symptômes peuvent devenir plus graves et fréquents."
}
},
{
"@type": "Question",
"name": "Comment prévenir les infections chez les patients déficients ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une bonne hygiène, des vaccinations et un suivi médical régulier sont essentiels."
}
},
{
"@type": "Question",
"name": "L'alimentation joue-t-elle un rôle dans la prévention ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une alimentation équilibrée peut renforcer le système immunitaire et la santé globale."
}
},
{
"@type": "Question",
"name": "Les exercices physiques sont-ils bénéfiques ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'exercice régulier peut améliorer la santé immunitaire et réduire le stress."
}
},
{
"@type": "Question",
"name": "Y a-t-il des mesures spécifiques à prendre ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Éviter les foules et se laver les mains fréquemment sont des mesures préventives clés."
}
},
{
"@type": "Question",
"name": "Les consultations médicales régulières sont-elles importantes ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des consultations régulières permettent de surveiller la santé et d'ajuster les traitements."
}
},
{
"@type": "Question",
"name": "Quels traitements sont disponibles pour les déficiences en lectines ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements incluent des thérapies immunomodulatrices et des antibiotiques préventifs."
}
},
{
"@type": "Question",
"name": "Les suppléments peuvent-ils aider ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des suppléments nutritionnels peuvent soutenir le système immunitaire, mais pas spécifiquement les lectines."
}
},
{
"@type": "Question",
"name": "La vaccination est-elle recommandée ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les vaccinations peuvent aider à prévenir les infections chez les patients à risque."
}
},
{
"@type": "Question",
"name": "Y a-t-il des traitements expérimentaux ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des recherches sont en cours sur des thérapies géniques et des traitements ciblés."
}
},
{
"@type": "Question",
"name": "Les traitements sont-ils personnalisés ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les traitements peuvent être adaptés en fonction des besoins individuels du patient."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec une déficience en lectines ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent des infections graves, des maladies auto-immunes et des allergies."
}
},
{
"@type": "Question",
"name": "Les infections peuvent-elles être mortelles ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines infections peuvent être fatales si elles ne sont pas traitées rapidement."
}
},
{
"@type": "Question",
"name": "Y a-t-il un risque accru de cancer ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines études suggèrent un risque accru de cancer chez les patients immunodéprimés."
}
},
{
"@type": "Question",
"name": "Les complications sont-elles réversibles ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines complications peuvent être gérées, mais d'autres peuvent causer des dommages permanents."
}
},
{
"@type": "Question",
"name": "Comment surveiller les complications ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des examens réguliers et des tests de laboratoire aident à surveiller les complications potentielles."
}
},
{
"@type": "Question",
"name": "Quels sont les facteurs de risque pour les déficiences en lectines ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les antécédents familiaux, les infections fréquentes et certaines maladies génétiques sont des facteurs de risque."
}
},
{
"@type": "Question",
"name": "L'âge influence-t-il le risque ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les jeunes enfants et les personnes âgées sont plus susceptibles de présenter des déficiences."
}
},
{
"@type": "Question",
"name": "Les maladies auto-immunes augmentent-elles le risque ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les personnes atteintes de maladies auto-immunes peuvent avoir un risque accru de déficiences."
}
},
{
"@type": "Question",
"name": "Le mode de vie affecte-t-il le risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un mode de vie malsain, comme le tabagisme, peut augmenter le risque de déficiences immunitaires."
}
},
{
"@type": "Question",
"name": "Les infections chroniques sont-elles un facteur de risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les infections chroniques peuvent affaiblir le système immunitaire et augmenter le risque."
}
}
]
}
]
}
The European Association of Urology, together with consortium partners, has launched PRAISE-U (Prostate Cancer Awareness and Initiative for Screening in the European Union), a project involving 25 ins...
Lung cancer is a prevalent cancer type worldwide that often remains asymptomatic in its early stages and is frequently diagnosed at an advanced stage with a poor prognosis due to the lack of effective...
Cancer screening provision in resource-constrained settings tends to be opportunistic, and uptake tends to be low, leading to delayed presentation and treatment and poor survival....
The aim of this study was to identify, review, map, and summarize findings from different types of literature reviews on the use of mobile health (mHealth) technologies to improve the uptake of cancer...
The review methodology was guided by the PRISMA-ScR (Preferred Reporting Items for Systematic Reviews and Meta-Analyses extension for Scoping Reviews). Ovid MEDLINE, PyscINFO, and Embase were searched...
Our initial search identified 1981 titles, of which 12 (0.61%) reviews met the inclusion criteria (systematic reviews: n=6, 50%; scoping reviews: n=4, 33%; rapid reviews: n=1, 8%; narrative reviews: n...
mHealth interventions increase cancer screening uptake, although multiple modes used in combination seem to be more effective....
Pancreatic ductal adenocarcinoma (PDAC) is frequently detected in late stages, which leads to limited therapeutic options and a dismal overall survival rate. To date, no robust method for the detectio...
Early detection of esophageal squamous cell carcinoma (ESCC) will facilitate curative treatment. We aimed to establish a microRNA (miRNA) signature derived from salivary extracellular vesicles and par...
Salivary EVP miRNA expression was profiled in a pilot cohort (n = 54) using microarray. Area under the receiver operator characteristic curve (AUROC) and least absolute shrinkage and selector operatio...
The microarray analysis identified 7 miRNAs for distinguishing patients with ESCC from control subjects. Because 1 was not always detectable in the discovery cohort and cell lines, the other 6 miRNAs ...
The salivary EVP-based 6-miRNA signature can serve as noninvasive biomarkers for early detection and risk stratification of ESCC. Chinese Clinical Trial Registry, ChiCTR2000031507....
Single vesicle molecular profiling has the potential to transform cancer detection and monitoring by precisely probing cancer-associated extracellular vesicles (EVs) in the presence of normal EVs in b...
Gastric cancer remains a formidable health challenge worldwide; early detection and effective surgical intervention are critical for improving patient outcomes. This comprehensive review explores the ...
Cancer remains a leading cause of death worldwide, partly owing to late detection which entails limited and often ineffective therapeutic options. Most cancers lack validated screening procedures, and...
There are four solid tumors with common screening options in the average-risk population aged 21 to 75 years (breast, cervical, colorectal, and, based on personalized risk assessment, prostate), but m...
Georgia is an upper middle-income country, which has lower cancer survival rates than most of the countries in the World Health Organization European region, as well as compared to many other post-Sov...
Descriptive analysis of the population-based cancer registry of Georgia was performed using the data for the period of 01.01.2018-31.12.2019....
Around 57 % of cancers in males and 56 % of cancers in females were amenable to early detection. At least 35.7 % of these cancers in males and 44.2 % in females were detected early. 15.2 % (n = 964) o...
The potential of early cancer detection is underutilised in Georgia and there is a need to strengthen screening and especially early diagnosis in the country. The possibility of thyroid cancer overdia...